Surgical Hemostats Market Outlook:
Surgical Hemostats Market size was over USD 4.51 billion in 2025 and is anticipated to cross USD 8.23 billion by 2035, witnessing more than 6.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of surgical hemostats is assessed at USD 4.76 billion.
The escalating number of surgical procedures worldwide stands out as the primary catalyst propelling the growth of the surgical hemostats industry. In recent years, there has been a notable surge in both elective and emergency surgeries, contributing to an augmented need for effective hemostatic solutions since they are crucial in preventing excessive blood loss and ensuring a safe and successful surgery. According to a report by the World Health Organization (WHO), the global volume of surgical procedures is poised to exceed 300 million annually.
In addition, factors that are believed to fuel the market expansion of surgical hemostats include technological advancements. Innovations such as the development of hemostatic agents with improved clotting mechanisms and quicker onset times contribute significantly to patient outcomes. Surgeons increasingly favor these advanced technologies, appreciating their role in minimizing complications and enhancing overall surgical success rates. A study highlighted that the adoption of advanced hemostatic technologies has resulted in a 25% reduction in postoperative bleeding complications across various surgical procedures.
